Chemoinformaics analysis of Phenylheptatriene
| Molecular Weight | 170.255 | nRot | 3 |
| Heavy Atom Molecular Weight | 156.143 | nRig | 9 |
| Exact Molecular Weight | 170.11 | nRing | 1 |
| Solubility: LogS | -4.089 | nHRing | 0 |
| Solubility: LogP | 4.409 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 1 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 27 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 13 | No. of Aromatic Carbocycles | 1 |
| nHetero | 0 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 14 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 13 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 6 |
| No. of Oxygen atom | 0 | No. of Arom Bond | 6 |
| nHA | 0 | APOL | 31.0451 |
| nHD | 0 | BPOL | 14.0449 |
| QED | 0.605 |
| Synth | 2.32 |
| Natural Product Likeliness | 0.722 |
| NR-PPAR-gamma | 0.002 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Rejected |
| Pgp-inh | 0.126 |
| Pgp-sub | 0.083 |
| HIA | 0.004 |
| CACO-2 | -4.677 |
| MDCK | 0.0000251 |
| BBB | 0.41 |
| PPB | 0.972531 |
| VDSS | 1.573 |
| FU | 0.0266304 |
| CYP1A2-inh | 0.885 |
| CYP1A2-sub | 0.876 |
| CYP2c19-inh | 0.193 |
| CYP2c19-sub | 0.896 |
| CYP2c9-inh | 0.071 |
| CYP2c9-sub | 0.77 |
| CYP2d6-inh | 0.026 |
| CYP2d6-sub | 0.927 |
| CYP3a4-inh | 0.019 |
| CYP3a4-sub | 0.382 |
| CL | 7.126 |
| T12 | 0.558 |
| hERG | 0.464 |
| Ames | 0.932 |
| ROA | 0.391 |
| SkinSen | 0.981 |
| Carcinogencity | 0.186 |
| EI | 0.987 |
| Respiratory | 0.939 |
| NR-Aromatase | 0.237 |
| Antiviral | No |
| Prediction | 0.612135 |